Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials.
Silveira
Claudio
C
Gargano
Nicola
N
Kijlstra
Aize
A
Petersen
Eskild
E
D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic / Q000592:standards*; D023381:Endpoint Determination / Q000592:standards*; D006801:Humans; D007223:Infant; D016052:Protozoan Vaccines; D018401:Sample Size; D014122:Toxoplasma / Q000276:immunology*; D014126:Toxoplasmosis, Ocular / Q000469:parasitology / Q000517:prevention & control*
D016052:Protozoan Vaccines